New Cannnabis / Health and Wellness Listing - Glow LifeTech Corp. (CSE:GLOW)

March 11, 2021 (Investorideas.com Newswire) The common shares of Glow LifeTech Corp. have been approved for listing on the CSE.

Listing and disclosure documents will be available at www.thecse.com on the trading date.

Glow LifeTech is a Canadian-based biotechnology company focused on producing nutraceutical and cannabinoid-based products with dramatically enhanced bioavailability, absorption and effectiveness. Glow LifeTech has rights to the groundbreaking, plant-based MyCell Technology® delivery system, which transforms poorly absorbed natural compounds into enhanced water-compatible concentrates, unlocking the full healing potential of natural active compounds.

______________________

Les actions ordinaires de Glow LifeTech Corp. ont été approuvées pour inscription au CSE.

Les documents d'inscription et de divulgation seront disponibles sur www.thecse.com à la date de négociation.

Glow LifeTech est une société de biotechnologie basée au Canada qui se concentre sur la production de produits nutraceutiques et à base de cannabinoïdes avec une biodisponibilité, une absorption et une efficacité considérablement améliorées. Glow LifeTech détient les droits sur le système d'administration révolutionnaire MyCell Technology® à base de plantes, qui transforme les composés naturels mal absorbés en concentrés améliorés compatibles avec l'eau, libérant ainsi tout le potentiel de guérison des composés actifs naturels.

The Exchange is accepting Market Maker applications for GLOW. Please email: Trading@theCSE.com

If you have any questions or require further information please contact Listings at (416) 367-7340 or E-mail: Listings@thecse.com

Pour toute question, pour obtenir de l'information supplémentaire veuillez communiquer avec le service des inscriptions au 416 367-7340 ou par courriel à l'adresse: Listings@thecse.com

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.

More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Buy a cannabis guest post on Investorideas.com